Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

281 trials

NCT06676631
Recruiting
NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
Phase 1 · China · 1 site
Registry update: 12 Jun 2026
NCT06941129
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 29 Sept 2025
NCT06921239
Recruiting
HLA Antibodies in Systemic Lupus Erythematosus
Not applicable · France · 1 site
Registry update: 16 Jan 2026
NCT06349343
Recruiting
CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Phase 1 · China · 1 site
Registry update: 26 Mar 2025
NCT06887517
Recruiting
Chinese Rheumatism Biobank(CRB)
Not applicable · China · 1 site
Registry update: 9 Apr 2025
NCT06841042
Recruiting
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Phase 1/2 · China · 14 sites
Registry update: 21 Feb 2025
NCT06785519
Recruiting
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
Early phase 1 · China · 1 site
Registry update: 21 Jan 2025
NCT06613360
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Phase 1 · Australia, Bulgaria, Germany, Spain, France, Georgia, Moldova, Poland, Romania, United States · 27 sites
Registry update: 26 Oct 2026
NCT06737380
Recruiting
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Phase 1 · United States · 1 site
Registry update: 11 Sept 2025
NCT06614270
Recruiting
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 29 Dec 2025
NCT06710717
Recruiting
Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
Phase 1 · Malaysia · 1 site
Registry update: 29 May 2025
NCT06365359
Recruiting
Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
Not applicable · France · 1 site
Registry update: 31 Mar 2025
NCT07017868
Recruiting
Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
Not applicable · Egypt · 1 site
Registry update: 12 Jun 2025
NCT07148115
Recruiting
Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus
Not applicable · Algeria · 2 sites
Registry update: 31 Dec 2025
NCT06794008
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · China · 1 site
Registry update: 2 Apr 2025
NCT06711146
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
Early phase 1 · China · 1 site
Registry update: 24 Aug 2026
NCT06465147
Recruiting
REACT-01: Reversing Autoimmunity Through Cell Therapy
Phase 1 · United States · 1 site
Registry update: 12 Dec 2025
NCT06789107
Recruiting
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Phase 1 · China · 1 site
Registry update: 28 Nov 2025
NCT06718283
Recruiting
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
Not applicable · Egypt · 1 site
Registry update: 5 Dec 2024
NCT06617325
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Phase 3 · United Arab Emirates, Argentina, Belgium, Canada, Chile, China, Germany, Denmark, Spain, France, United Kingdom, Greece, Italy, Japan, South Korea, Mexico, Netherlands, Peru, Poland, Puerto Rico, Serbia, Taiwan, United States · 253 sites
Registry update: 2 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.